Home > Boards > US Listed > Medical - Drugs > Homology Medicines Inc (FIXX)

CFO is from PFE and Shire and the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
MWM Member Profile
Member Level 
Followed By 1,022
Posts 137,445
Boards Moderated 16
Alias Born 03/31/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 4:10:48 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/8/2021 4:05:44 PM
Homology Medicines Reports Second Quarter 2021 Financial Results and Recent Highlights GlobeNewswire Inc. - 8/12/2021 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/12/2021 4:03:44 PM
Homology Medicines Appoints Gene Therapy Pioneer Beverly Davidson, Ph.D., as Chair of Scientific Advisory Board GlobeNewswire Inc. - 8/5/2021 8:30:00 AM
Homology Medicines to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 8/4/2021 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2021 5:42:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2021 5:41:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2021 5:41:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2021 5:40:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2021 5:40:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2021 5:36:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2021 5:35:48 PM
Homology Medicines Announces Presentations on its Expanding Genetic Medicines Platform and Internal GMP Manufacturing at the ... GlobeNewswire Inc. - 5/13/2021 7:00:00 AM
Homology Medicines EPS beats by $0.62, beats on revenue Seeking Alpha - 5/6/2021 5:11:10 PM
Homology Medicines Reports First Quarter 2021 Financial Results and Recent Highlights GlobeNewswire Inc. - 5/6/2021 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 4:04:09 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 5/6/2021 1:48:50 PM
Homology Medicines Presents Data Demonstrating In Vivo Transduction of Non-Human Primate and Human Retinal Cells at ARVO Annu... GlobeNewswire Inc. - 5/3/2021 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2021 4:05:26 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2021 4:02:33 PM
Homology Medicines Announces New Approach to Leverage AAVHSC Platform by Delivering One-Time In Vivo Gene Therapy to Produce ... GlobeNewswire Inc. - 4/28/2021 8:00:00 AM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 4/19/2021 1:17:51 PM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 4/19/2021 1:17:21 PM
Homology Medicines Announces Presentations at ACMG Annual Clinical Genetics Meeting GlobeNewswire Inc. - 4/14/2021 8:30:00 AM
MWM Member Level  Friday, 01/15/21 03:11:18 PM
Re: Rockurstocks post# 23
Post # of 33 
CFO is from PFE and Shire and the rest of management is all from Shire...

Shire
Biotechnology company

Shire plc was a Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019. Wikipedia
Headquarters: Lexington, MA
CEO: Flemming Ørnskov (Apr 30, 2013–)
Revenue: 15.16 billion USD
Number of employees: 23,044 (2018)

Parent organization: Takeda Pharmaceutical Company

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences